Sucampo

A star drug in Mallinckrodt’s $1.2B Sucampo buyout flops in pivotal trial
A star drug in Mallinckrodt’s $1.2B Sucampo buyout flops in pivotal trial
Endpoints
Mallinckrodt
Sucampo
Niemann-Pick disease
Flag link:
Mother Alleges Biotech Firm Stole Data From Her Sick Children
Mother Alleges Biotech Firm Stole Data From Her Sick Children
Forbes
biotech
Sucampo
Vtesse
Cydan
patient data
Flag link:
Mallinckrodt builds pipeline through $1.2B Sucampo deal
Mallinckrodt builds pipeline through $1.2B Sucampo deal
Biopharma Dive
Mallinckrodt
Sucampo
M&A
Flag link:
8 Takeout targets to watch in 2018
8 Takeout targets to watch in 2018
BioPharma Dive
M&A
Allergan
Alnylam
Biomarin
Bristol-Myers Squibb
Incyte
Madrigal Pharmaceuticals
Spark Therapeutics
Sucampo
Flag link:
Here’s why Sucampo paid $200M for its PhIII Niemann-Pick drug
Here’s why Sucampo paid $200M for its PhIII Niemann-Pick drug
Endpoints
Sucampo
Niemann-Pick disease
cyclodextrin
Flag link:
Sucampo bags rare disease player Vtesse in $200M buyout agreement
Sucampo bags rare disease player Vtesse in $200M buyout agreement
Endpoints
Sucampo
Vtesse
M&A
VTS-270
Flag link:
Sucampo tops 4Q revenue forecasts
Sucampo tops 4Q revenue forecasts
Yahoo/AP
Sucampo
earnings
Flag link:
Sucampo Q4 Beats Estimates, Affirms Guidance, Driving Up Stock
Sucampo Q4 Beats Estimates, Affirms Guidance, Driving Up Stock
Investors.com
Sucampo
earnings
Flag link:
10 Best Nasdaq Biotech Stocks in the Third Quarter
10 Best Nasdaq Biotech Stocks in the Third Quarter
TheStreet.com
Incyte
Myriad
Cara Therapeutics
Sucampo
ZS Pharma
Concert Pharmaceuticals
The Medicines Company
Lexicon Pharmaceuticals
Exelixis
Anacor
Flag link:
Why does Sucampo want to acquire its founders' Japanese company? Transformation.
Why does Sucampo want to acquire its founders' Japanese company? Transformation.
Bizjournals.com
Sucampo
Japan
M&A
Flag link:
Sucampo Pharma to Make Tender Offer For Japan's R-Tech Ueno
Sucampo Pharma to Make Tender Offer For Japan's R-Tech Ueno
Bloomberg
Sucampo
M&A
Japan
R-Tech Ueno
Flag link:
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
biotech
Threshold Pharmaceuticals
Acceleron
Spectrum Pharmaceuticals
Ultragenyx
Argos Therapeutics
OncoMed
Peregrine Pharmaceuticals
Incyte
Calithera
Array Biopharma
Theravance
Puma Biotechnology
CTI BioPharma
Orexigen
Enanta Pharmaceuticals
Sucampo
Exelixis
Cubist Pharmaceuticals
United Therapeutics
Flag link:
Sucampo posts profit of $1.5 million in third quarter
Sucampo posts profit of $1.5 million in third quarter
Yahoo/AP
Sucampo
earnings
Flag link:
Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone)
Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone)
Yahoo
Takeda
Sucampo
Amitiza
Flag link:
Previous Data Signals Positive Phase IIb Results Likely To Come For Synergy Pharmaceuticals
Previous Data Signals Positive Phase IIb Results Likely To Come For Synergy Pharmaceuticals
Seeking Alpha
Synergy Pharmaceuticals
IBS-C
Ironwood Pharmaceuticals
Linzess
Sucampo
plecanatide
Flag link:
Sucampo initiates global Phase 3 clinical program of lubiprostone
Sucampo initiates global Phase 3 clinical program of lubiprostone
The Fly on the Wall
Sucampo
Lubiprostone
pediatric functional constipation
Flag link:
Sucampo CEO search an unexpected positive, says Cantor
Sucampo CEO search an unexpected positive, says Cantor
Yahoo/Fly on the Wall
Sucampo
Flag link:
Sucampo Receives $10 Million Milestone Payment from Takeda on First Sale of AMITIZA® (lubiprostone) for OIC in the US
Sucampo Receives $10 Million Milestone Payment from Takeda on First Sale of AMITIZA® (lubiprostone) for OIC in the US
Yahoo
Sucampo
Takeda
Amitiza
opioid-induced constipation
Flag link:
Sucampo to be Added to the NASDAQ Biotechnology Index
Sucampo to be Added to the NASDAQ Biotechnology Index
Yahoo
NASDAQ
Sucampo
Flag link:
Sucampo Wins Approval for Expanded Use of Amitiza in U.S.
Sucampo Wins Approval for Expanded Use of Amitiza in U.S.
Bloomberg
Sucampo
Amitiza
opioid-induced constipation
Flag link:

Pages